ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer
Breast Cancer: Articles
Expert Shares Insight on Recent Advances in HER2+ Breast Cancer
10:53 AM, Mon March 5, 2018
A Look Back at FDA News in the Month of February
4:00 PM, Fri March 2, 2018
Frontline Abemaciclib Granted FDA Approval for HR+/HER2- Breast Cancer
5:55 PM, Mon February 26, 2018
Significant Benefit of Adjuvant Chemo in ER-Negative, Locally Recurrent Breast Cancer Sustained
4:24 PM, Fri February 23, 2018
Off-the-Shelf Vaccine Investigated in Phase II Study of TNBC for Recurrence Prevention
11:11 AM, Tue February 13, 2018
Priyanka Sharma Named Vice Chair of SWOG Breast Committee
9:17 AM, Tue February 13, 2018
Promising Findings for Alpelisib in Patients With PIK3CA-Altered Metastatic ER+/HER2- Breast Cancer
2:44 PM, Fri February 9, 2018
Eflapegrastim Provides Superior Neutropenia Control Over Pegfilgrastim in Phase III Breast Cancer Study
5:40 PM, Mon February 5, 2018
